Zymeworks to Present at Raymond James 41st Annual Institutional Investors Conference
February 24 2020 - 8:30AM
Business Wire
Zymeworks Inc. (NYSE:ZYME), a clinical-stage biopharmaceutical
company developing multifunctional therapeutics, today announced
that the Company will present at the upcoming Raymond James
Institutional Investors Conference taking place March 1-4, 2020 in
Orlando, FL.
The Company’s presentation will be on Monday, March 2, 2020 at
2:15 p.m. ET.
Interested parties can access a live webcast of the presentation
via a link from Zymeworks’ website at
http://ir.zymeworks.com/events-and-presentations, which will also
host a recorded replay available afterwards.
About Zymeworks Inc.
Zymeworks is a clinical-stage biopharmaceutical company
dedicated to the development of next-generation multifunctional
biotherapeutics. Zymeworks’ suite of therapeutic platforms and its
fully integrated drug development engine enable precise engineering
of highly differentiated product candidates. Zymeworks’ lead
clinical candidate, ZW25, is a novel Azymetric™ bispecific antibody
currently in Phase 2 clinical development. Zymeworks’ second
clinical candidate, ZW49, is a bispecific antibody-drug conjugate
currently in Phase 1 clinical development and combines the unique
design and antibody framework of ZW25 with Zymeworks’ proprietary
ZymeLink™ cytotoxic payload. Zymeworks is also advancing a deep
preclinical pipeline in oncology (including immuno-oncology agents)
and other therapeutic areas. In addition, its therapeutic platforms
are being leveraged through strategic partnerships with nine
biopharmaceutical companies. For more information, visit
www.zymeworks.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200224005181/en/
Zymeworks Inc.
Investor Inquiries: Ryan Dercho, Ph.D. (604) 678-1388
ir@zymeworks.com
Tiffany Tolmie (604) 678-1388 ir@zymeworks.com
Media Inquiries: Kavita Shah, Ph.D. (604) 678-1388
info@zymeworks.com
Zymeworks (NYSE:ZYME)
Historical Stock Chart
From Mar 2024 to Apr 2024
Zymeworks (NYSE:ZYME)
Historical Stock Chart
From Apr 2023 to Apr 2024